Identification of 'short-lived' and 'long-lived' patients at presentation of idiopathic myelofibrosis

British Journal of Haematology

Volumn 97, Issue 3, 1997, Pages 635-640

  Cervantes, Francisco ^a,b   Pereira, Arturo ^a   Esteve, Jordi ^a   Rafel, Montserrat ^a   Cobo, Francesc ^a   Rozman, Ciril ^a   Montserrat, Emilio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

idiopathic myelofibrosis; prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELOFIBROSIS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; SURVIVAL; THROMBOCYTE COUNT;

EID: 0031003622     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.782714.x     Document Type: Article

References (24)

1. Barosi, G., Berzuini, C., Liberato, L.N., Costa, A., Polino, G. & Ascari, E. (1988) A prognostic classification of myelofibrosis with myeloid metaplasia. British Journal of Haematology, 70, 397-401.
2. Bouroncle, B. & Doan, C.A. (1962) Myelofibrosis: clinical, hematologic and pathologic study of 110 patients. American Journal of the Medical Sciences, 243, 697-715.
3. Burkhardt, R., Bartl, R., Frisch, B., Ketter, G., Mahl, G. & Sund, M. (1986) Working formulation of chronic myeloproliferative disorders based on histological, haematological, and clinical findings. Journal of Clinical Pathology, 39, 237-252.
4. Cervantes, F., Robertson, J.E., Rozman, C., Baccarani, M., Tura, S., Gómez, G.A., Braun, T.J., Clarkson, B.D., Pereira, A., and the Italian Cooperative CML Study Croup (1994) Long-term survivors in chronic granulocytic leukaemia: a study by the International CGL Prognosis Study Group. British Journal of Haematology, 87, 293-300.
5. Cox, D.R. (1972) Regression models and life tables. Journal of the Royal Statistical Society (B), 34, 187-220.
6. Demory, J.L., Dupriez, B., Fenaux, P., Laï, J.L., Beuscart, R., Jouet, J., Deminatti, M. & Bauters, F. (1988) Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases. Blood, 72, 855-859.
7. Dixon, W.J., Brown, M.B., Engelman, L., Hill, M.A. & Jennrich, R.I. (1988) BMDP Statistical Software, pp. 719-743. University of California Press, Berkeley.
8. Dupriez, B., Morel, P., Demory, J.L., Lai, J.L., Simon, M., Plantier, I. & Bauters, F. (1996) Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood, 88, 1013-1018.
9. Hasselbach, H. (1990) Idiopathic myelofibrosis: a review. European Journal of Haematology, 45, 65-72.
10. Kaplan, E.L. & Meier, P. (1958) Non-parametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
11. Lawler, S.D. & Swansbury, G.J. (1985) Cytogenetic studies in myelofibrosis and related conditions. Myelofibrosis: Pathophysiology and Clinical Management (ed. by S. M. Lewis), pp. 167-194. Marcel Dekker, New York.
12. Lennert, K., Naghai, K. & Schwarze, E.W. (1975) Patho-anatomical features of the bone marrow. Clinics in Haematology, 4, 331-351.
13. Manoharan, A. (1988) Myelofibrosis: prognostic factors and treatment. British Journal of Haematology, 69, 295-298.
14. Manoharan, A., Smart, R.C. & Pitney, W.R. (1982) Prognostic factors in myelofibrosis. Pathology, 14, 55-461.
15. Mantel, N. (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy Reports, 50, 163-170.
16. Miller, J.B., Testa, J.R., Lindgren, V. & Rowley, J.D. (1985) The pattern and clinical significance of karyotypic abnormalities in patients with idiopathic and postpolycythemic myelofibrosis. Cancer, 55, 582-591.
17. Njoku, O.S., Lewis, S.M., Catovsky, D. & Gordon-Smith, E.C. (1985) Anaemia in myelofibrosis: its value in prognosis. British Journal of Haematology, 54, 79-89.
18. Pereira, A., Cervantes, F., Brugués, R. & Rozman, C. (1990) Bone marrow histopathology in primary myelofibrosis: clinical and haematologic correlations and prognostic evaluation. European Journal of Haematology, 44, 94-98.
19. Rupoli, S., Da Lio, L., Sisti, S., Campanati, G., Salvi, A., Brianzoni, M.F., D'Amico, S., Cincipirini, A. & Leoni, P. (1994) Primary myelofibrosis: a detailed statistical analysis of the clinicopathological variables influencing survival. Annals of Hematology, 68, 205-212.
20. Silverstein, M.N. (1985) Treatment of myelofibrosis. Myelofibrosis: Pathophysiology and Clinical Management (ed. by S. M. Lewis), pp. 195-202. Marcel Dekker, New York.
21. Thiele, J., Kvasnicka, H.M., Werden, C., Zancovich, R., Diehl, V. & Fischer, R. (1996) Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact. Leukemia and Lymphoma, 22, 303-317.
22. Varki, A., Lottenberg, R., Griffith, R. & Reinhard, E. (1983) The syndrome of idiopathic myelofibrosis: a clinico-pathologic review with emphasis on the prognostic variables predicting survival. Medicine, 62, 353-371.
23. Visani, G., Finelli, C., Castelli, U., Petti, M.C., Ricci, P., Vianelli, N., Gianni, G., Zuffa, E., Aloe Spiriti, M.A., Latagliata, R., Pileri, S., Magrini, U., Gugliotta, L., Morra, E., Bernasconi, C., Mandelli, F. & Tura, S. (1990) Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients. British Journal of Haematology, 75, 4-9.
24. Ward, H.P. & Block, M.H. (1971) The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with myeloproliferative syndromes. Medicine, 50, 357-420.